Answers are grounded in this paper and cite their sources.
A detailed study of structure-activity relationship (SAR) in a series of phenyl dihydrouracil (PHDU) derivatives as promising chemotypes for protein degrader discovery is reported. Evaluation of cereblon binding for several dozen PHDU-derived building blocks showed that over 20 compounds with various substituents at the phenyl ring showed over 50% displacement of labeled Thalidomide at 10 M. Most potent representatives bearing methyl substituent were used to synthesize 72 PROTACs by conjugating with JQ-1 though a series of linear linkers with or without additional heteroatoms. A series of assays (including binary and ternary complex formation, as well as cell-based BRD4 degradation) allowed establishing SAR trends regarding the linker nature and length. Compounds with (CH₂)₅, (CH₂)₆, and especially (CH₂)₁₁ linkers demonstrated the best results in both BRD4 degradation (DC₅₀ = 16–52 nM) and cell viability assays. The most potent representatives (2/5-Me-PDHU11) can be promising tools for biomedical research.
No takes yet. Share an insight, caveat, or question.
Shyshlyk et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: